23.06
Precedente Chiudi:
$24.55
Aprire:
$24.93
Volume 24 ore:
249.25K
Relative Volume:
1.26
Capitalizzazione di mercato:
$1.02B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-10.34%
1M Prestazione:
+34.70%
6M Prestazione:
+55.81%
1 anno Prestazione:
+0.00%
Sionna Therapeutics Inc Stock (SION) Company Profile
Nome
Sionna Therapeutics Inc
Settore
Industria
Telefono
617-819-2020
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Confronta SION con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SION
Sionna Therapeutics Inc
|
23.06 | 1.12B | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-04 | Iniziato | Guggenheim | Buy |
2025-03-04 | Iniziato | Stifel | Buy |
2025-03-04 | Iniziato | TD Cowen | Buy |
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
Ridloff Elena, CFO, sells Sionna (SION) shares for $240k - Investing.com
How to build a custom watchlist for Sionna Therapeutics Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser
Combining price and volume data for Sionna Therapeutics Inc.July 2025 Levels & Low Risk Entry Point Guides - Newser
RBC Capital Initiates Sionna Therapeutics at Sector Perform With $22 Price Target - MarketScreener
Sionna Therapeutics Inc. recovery potential after sell offTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Best data tools to analyze Sionna Therapeutics Inc. stockTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Is Sionna Therapeutics Inc. on track to beat earningsIPO Watch & Pattern Based Trade Signal System - khodrobank.com
Visual analytics tools that track Sionna Therapeutics Inc. performanceQuarterly Portfolio Report & Real-Time Volume Analysis - Newser
Pattern recognition hints at Sionna Therapeutics Inc. upsideFed Meeting & Low Drawdown Trading Strategies - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Market Review & Technical Confirmation Alerts - Newser
What the charts say about Sionna Therapeutics Inc. todayJuly 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Trend analysis for Sionna Therapeutics Inc. this weekTrade Volume Summary & Growth Focused Entry Point Reports - Newser
Tick level data insight on Sionna Therapeutics Inc. volatility2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionInsider Selling & Accurate Buy Signal Alerts - Newser
Will Sionna Therapeutics Inc. outperform the marketMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
Can Sionna Therapeutics Inc. outperform in the next rallyJuly 2025 Action & Accurate Intraday Trade Tips - khodrobank.com
Real time scanner hits for Sionna Therapeutics Inc. explainedWeekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
Price momentum metrics for Sionna Therapeutics Inc. explainedTrade Performance Summary & Safe Entry Zone Identification - Newser
Risk vs reward if holding onto Sionna Therapeutics Inc.Market Performance Report & Community Shared Stock Ideas - Newser
Detecting support and resistance levels for Sionna Therapeutics Inc.Weekly Market Report & Weekly Top Gainers Alerts - Newser
How moving averages guide Sionna Therapeutics Inc. tradingIPO Watch & Real-Time Chart Pattern Alerts - Newser
Sionna Therapeutics Inc. stock prediction for this weekJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Can Sionna Therapeutics Inc. sustain its profitability2025 Market WrapUp & AI Based Buy/Sell Signal Reports - khodrobank.com
Sionna Therapeutics Inc. stock outlook for YEARJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
Sionna Therapeutics Inc. Enters Reversal Setup in Weekly Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Full technical analysis of Sionna Therapeutics Inc. stockPortfolio Gains Summary & Daily Price Action Insights - Newser
RSI Divergence May Trigger a Bounce in Sionna Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Sentiment analysis tools applied to Sionna Therapeutics Inc.Portfolio Performance Summary & Fast Moving Trade Plans - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser
What institutional flow reveals about Sionna Therapeutics Inc.Earnings Recap Report & Daily Growth Stock Tips - Newser
Real time pattern detection on Sionna Therapeutics Inc. stockJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.2025 Retail Activity & Verified Entry Point Signals - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.Trade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Sionna Therapeutics Inc Azioni (SION) Dati Finanziari
Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Sionna Therapeutics Inc Azioni (SION) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 29 '25 |
Sale |
25.18 |
748 |
18,835 |
47,368 |
Cloonan Michael | President & CEO |
Aug 26 '25 |
Option Exercise |
6.11 |
17,574 |
107,377 |
564,917 |
Cloonan Michael | President & CEO |
Aug 27 '25 |
Option Exercise |
6.11 |
7,426 |
45,373 |
554,769 |
Cloonan Michael | President & CEO |
Aug 26 '25 |
Sale |
24.96 |
17,574 |
438,647 |
547,343 |
Cloonan Michael | President & CEO |
Aug 27 '25 |
Sale |
25.01 |
7,426 |
185,714 |
547,343 |
Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 28 '25 |
Sale |
25.97 |
16,098 |
418,065 |
48,116 |
Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 26 '25 |
Sale |
25.13 |
3,700 |
92,981 |
67,832 |
Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 27 '25 |
Sale |
25.10 |
3,618 |
90,812 |
64,214 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):